Breast Care

Papers
(The TQCC of Breast Care is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Persistence to Adjuvant Endocrine Therapy for Breast Cancer in Botswana: An Observational Cohort Analysis59
Erratum41
How Can Oncoplastic Breast Surgery Contribute to the Management of Locally Advanced Breast Cancer in Sub-Saharan Africa?33
Neurotization of the nipple-areola complex in nipple sparing mastectomy: systematic review of techniques, sensitivity and sexual well-being25
St. Gallen/Vienna 2025 Summary of Key Messages on Therapy in Early Breast Cancer from the 2025 St. Gallen International Breast Cancer Conference24
Breast-Conserving Surgery in Multicentric Breast Cancer: Progress, Pitfalls, and Risks24
Acknowledgement to Reviewers22
Front & Back Matter20
HER2+ Early Breast Cancer: From Escalation via Targeted and Post-Neoadjuvant Treatment to De-Escalation16
Overall Survival in Metastatic Breast Cancer Patients: Real-World Data from 1,000 Patients Treated at the NCT Heidelberg between 2014 and 202216
Predictors for Upgrade to Breast Cancer in Patients with B3 Lesions Diagnosed by Core Biopsy: A Retrospective Cohort Study14
Comparing the Efficacy of Intralesional Injection versus Systemic Steroids in Treating Idiopathic Granulomatous Mastitis: Insights from a Single-Center Experience14
Effects and Risks of Hormonal Therapy before and after BC Therapy14
PharmaNews13
Efficacy and Safety of Liposuction and Glandular Excision for Gynecomastia: Clinical Presentation, Immediate Outcome, and Patient Satisfaction: A Cohort Study12
Expert Discussion: ABC8, Bridging the Gap12
Impact of the National Action Plan for Antimicrobial Resistance on Antibiotic Use for Mastitis Using a Japanese Nationwide Database11
Conventional Tools for Predicting Satisfactory Response to Neoadjuvant Chemotherapy in HR+/HER2− Breast Cancer Patients10
Quality of Life after Alloplastic versus Autologous Breast Reconstruction: The Influence of Patient Characteristics on Outcomes9
Quality of Life in Patients Pre- and Post-Breast Reduction Surgery in a South African Population: A Single-Centred Patient-Based Study9
PharmaNews9
Sacituzumab govitecan: Trop-2 als Target8
Interview ABC7: Bridging the Gap8
Ten-Year Survival of Breast Cancer in Iran: A National Study (Retrospective Cohort Study)7
The risk of cardiovascular disease following aromatase inhibitor therapy for breast cancer in postmenopausal women: a systematic review and meta-analysis7
Breast Cancer-Related Lymphedema: A Common Challenge among Nigerian Breast Cancer Survivors6
Large-Scale Population Screening for BRCA1 and BRCA2 Ashkenazi Founder Mutations: Perspectives of Professionals Providing Oncogenetic Consultations6
Tamoxifen Treatment for Pubertal Gynecomastia: When to Start and How Long to Continue6
Expanding the Boundaries of Breast Conservation: Oncoplastic Surgery in Multifocal and Multicentric Breast Cancer6
Using Virtual Therapy for Lymphedema and Disability Post-Mastectomy: Meta-Analysis with Systematic Review6
Long-Term Follow-Up of High-Risk Breast Lesions at Vacuum-Assisted Biopsy without Subsequent Surgical Resection6
Which Patients Need Chemotherapy? From Pathological Risk Factors to Gene Signatures and Evaluation of Endocrine Response5
Primary Prevention and Early Detection of Hereditary Breast Cancer5
Comparison of local recurrence outcomes between breast conservation therapy and mastectomy for the treatment of breast cancer among young women: A systematic review and meta-analysis5
Analysis of Lifestyle and Genetic Risk Factors in Urban Women in China Who Had Malignant or Suspected Malignant Breast Nodules Identified via Breast Cancer Screening5
Effectiveness of Peer Support on Quality of Life and Anxiety in Breast Cancer Patients: A Systematic Review and Meta-Analysis5
Clinicopathological Factors Affecting Positive Margins after Breast-Conserving Surgery: A Comparative Study of Low- and High-Volume Hospitals5
Acknowledgement to Reviewers4
Non-Surgical Site Pain in Women following Breast Cancer Surgery: A Systematic Review and Meta-Analysis4
Biologically Based Complementary and Alternative Medicine Use in Breast Cancer Patients and Possible Drug-Drug Interactions4
Management of Idiopathic Granulomatous Mastitis: A Single Institution Experience4
Society Bulletins4
Banana Supplementation for Breast Cancer Surgery Patients: A Two-Center Experience4
Keeping a Breast with Social Media: “Le Marteau Sans Maître?”4
Association of Aromatase Inhibitor-Induced Musculoskeletal Symptoms with Central Sensitization-Related Symptoms: A Cross-Sectional Study3
Revisiting the Need for Breast Imaging in Young Women with Clinically Significant Breast Pain and a Normal Physical Breast Examination3
<i>TP53</i> Gene Polymorphism at Codon 72 as a Response Predictor for Neoadjuvant Chemotherapy3
Ultra-Hypofractionated Palliative Radiotherapy for Symptomatic Locoregionally Advanced Breast Cancer: A Prospective, Single-Arm Phase II Trial of Toxicity and Quality-of-Life Outcomes3
The Evolution of Educational Events during the COVID-19 Pandemic: The Experience of G.Re.T.A. Foundation3
PharmaNews3
Front & Back Matter3
Pre-Pectoral Breast Reconstruction after Mastectomy: Current Evidence, Knowledge Gaps, and Rationale for the I-PREPARE EUBREAST-11R Trial3
Acknowledgement to Reviewers3
Review Article a Multidisciplinary Evaluation for Advanced Supportive Care of Breast Cancer Patients3
Dose Comparison (1 mL versus 2 mL) of Superparamagnetic Tracer for Sentinel Node Biopsy in Early Breast Cancer: Real-World Analysis from 456 Patients3
37. Annual Meeting of the Austrian Society of Senology. Vienna, Austria, Sept. 8–9 2023. Abstracts3
Comparison of Intermittent Pneumatic Compression Pump as Adjunct to Decongestive Lymphatic Therapy against Decongestive Therapy Alone for Upper Limb Lymphedema after Breast Cancer Surgery: A Systemati3
PharmaNews3
Final Results from RIBBIT: A Randomized Phase III Study to Evaluate Efficacy and Quality of Life in Patients with Metastatic Hormone Receptor-Positive, HER2-Negative Breast Cancer Receiving Ribociclib3
The Challenge of Calculating EUSOMA Quality Indicators with Administrative Data: A Pilot Study in Belgium3
0.14968204498291